Waterfront Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MSR
PR
SO
WT
AAS
WAM
RFM
NHFG
RAM
Waterfront Wealth's XBI Position: Q2 2026 in Review
Waterfront Wealth held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,041 shares worth $325K. The position accounts for 0.05% of the portfolio, ranked #251.
Waterfront Wealth first reported a position in XBI in Q4 2021 and has held it in 17 quarters since. The position peaked at $420K in Q2 2022. 368 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Waterfront Wealth held 2,041 shares of State Street SPDR S&P Biotech ETF worth $325K as of Q2 2026.
- Waterfront Wealth left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.05% of Waterfront Wealth's portfolio in Q2 2026, its #251 holding.
- Waterfront Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 17 quarters since.
- Waterfront Wealth's State Street SPDR S&P Biotech ETF position peaked at $420K in Q2 2022.
- 368 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.